It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
With the exception of one president who came close to optimizing national resources and enhancing domestic revenue, subsequent presidents have failed, in their first two years, to devise a ...